Search for: "MERCK & CO., INC. "
Results 141 - 160
of 674
Sorted by Relevance
|
Sort by Date
19 Jan 2010, 9:01 pm
Causation in Vioxx cases Merck & Co., Inc. v. [read post]
26 Oct 2006, 6:09 pm
Recently a federal jury ruled in favor of Merck & Co. [read post]
27 Nov 2019, 3:33 am
Cir. 2015); seealso KSR Int’l Co. v. [read post]
4 Oct 2007, 11:13 am
Merck & Co, Inc., does not necessarily endorse the perspectives or opinions expressed within these statements. [read post]
6 Sep 2012, 11:00 am
Merck & Co., Inc., 06 Civ. 9455 (JFK), case is set for a new jury trial on damages before United States District Court Judge Joseph F. [read post]
6 Sep 2012, 11:00 am
Merck & Co., Inc., 06 Civ. 9455 (JFK), case is set for a new jury trial on damages before United States District Court Judge Joseph F. [read post]
4 Apr 2011, 1:15 pm
District Court for the Southern District of New York, which is limited to jaw injury cases, such as osteonecrosis of the jaw (ONJ).(6/6/11)______________________________________________________________________________ The following information about the ongoing Fosamax litigation comes from pages 128-129 of the Merck & Co., Inc. [read post]
23 Jun 2009, 2:44 pm
Merck Statement in Response to the FDA's June 12, 2009 Communication with Updated Information on Leukotriene Inhibitors, Including SINGULAIR ® (montelukast sodium) -- June 12, 2009 press release from Merck & Co., Inc. [read post]
3 Feb 2018, 8:58 pm
Jorge Goldstein of Sterne, Kessler, Goldstein & Fox, PLLC; Brian Kacedon of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; and William Krovatin of Merck & Co Inc. will discuss strategies and recent court cases that involve: • Staking out the claim that a sale is not an "authorized sale" — Chrimar v. [read post]
31 Oct 2021, 9:20 pm
Ashita Doshi of Thermo Fisher Scientific, Nichole Valeyko of Merck & Co., Ben Searle of HP Inc., and Todd Walters of Buchanan Ingersoll & Rooney PC will discuss strategies and practical tips for obtaining patent portfolios that survive post-grant attacks, including a discussion of the following topics: PTAB statistics, application drafting, claim drafting strategies, prosecution strategies, obtaining a robust portfolio, and knowing when and where to assert your... [read post]
20 Mar 2021, 8:45 pm
Brian Brookey of Tucker Ellis LLP; Serena Farquharson-Torres of Bristol-Meyers Squibb; Gloria Fuentes of Merck & Co. [read post]
31 Mar 2016, 7:07 am
Merck & Co., Inc. et al, 1-15-cv-00572 (DED March 29, 2016, Order) (Sleet, J.) [read post]
29 Sep 2009, 10:06 am
Also on September 25 Merck & Co., Inc. issued a statement saying its own analysis of the post-marketing adverse experience reports data did not confirm an excess risk for developing acute pancreatitis. [read post]
19 Jan 2016, 3:56 pm
Merck & Co., Inc., No. 5:13-cv-04057-BLF, 2016 WL 146574 (N.D. [read post]
1 Jun 2008, 7:36 pm
The Houston Chronicle ran an interesting commentary this weekend about the Houston Court of Civil Appeals overturning a plaintiff victory against Merck, Inc. in a Vioxx lawsuit. [read post]
12 Mar 2012, 6:04 am
Merck & Co. [read post]
27 Feb 2018, 12:24 pm
Industrial Co. v. [read post]
9 May 2012, 12:51 pm
Again, from the Merck & Co., Inc. [read post]
30 May 2019, 8:02 am
Merck & Co., Inc. [read post]
15 Nov 2010, 2:12 pm
Now, in November 2010, the FDA has approved a Supplemental New Drug Application (sNDA) submitted June 16, 2010 by Merck & Co., Inc. -- under section 505(b) of the Federal Food, Drug, and Cosmetic Act (FDCA) -- adding interstitial lung disease (ILD) to the "ADVERSE REACTIONS, Post-Marketing Experience, subsection of the Zocor package insert", or label. [read post]
